Clinical Trial Update: A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity [Phase 2]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 2 method development trial to evaluate a dentifrice for relief of dentin hypersensitivity, which has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Dentifrice (toothpaste) for dentin hypersensitivity (dentifrice)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dentin Sensitivity | Phase 2 | Status: WITHDRAWN